Clinical Trial Update: Symbicort in Asthmatic Children - SEEDLING [Phase 3]

View source ↗

Summary

SEEDLING is a Phase 3 trial evaluating Symbicort in children with asthma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED